Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms

NCT: NCT03728985 · ACTIVE_NOT_RECRUITING

NCT IDNCT03728985
StatusACTIVE_NOT_RECRUITING
Start Date2019-06-17
Completion2030-01
SponsorW.L.Gore & Associates (INDUSTRY)
First posted
Last updated

Brief Summary

Prospective, non-randomized, , multicenter study with two independent arms: * Primary Study Arm - TAAA and Pararenal aneurysms requiring only TAMBE System. Hypothesis-driven analysis. * Up to 65 additional subjects may be implanted in Continued Access Phase under the Primary Study Arm only * Secondary Study Arm - TAAA requiring TAMBE System and CTAG Device(s). Non hypothesis-driven analysis. Minimum: 122 implanted subjects. Maximum: 202 implanted subjects with up to 65 additional subjects implanted in Continued Access (Primary Study arm)

Frequently Asked Questions

What is Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms?

Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms is a clinical trial registered under NCT03728985. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03728985?

The current status of NCT03728985 (Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms) is: ACTIVE_NOT_RECRUITING.

When did Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms start?

Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms started on 2019-06-17.

Related Devices

PMA P230023Endovascular system for treatment of thoracoabdominal and pararenal aortic lesionsW. L. Gore & Associates, Inc. K170740GORE VIABIL Short Wire Biliary EndoprosthesisW. L. Gore & Associates, Inc. PMA P020004SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTW. L. Gore & Associates, Inc. PMA P040043SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTW. L. Gore & Associates, Inc. PMA P130006System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatmentW. L. Gore & Associates, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑